Aspergillosis in systemic diseases treated with steroids and/or immunosuppressive drugs: report of 9 cases and literature review;Aspergilloses au cours de maladies systémiques traitées par corticoïdes et/ou immunosuppresseurs : analyse de neuf cas et revue de la littérature

Revue de Medecine Interne

Volumn 27, Issue 11, 2006, Pages 813-827

  Stankovic, K ^a   Seve P ^a   Hot, A ^b   Magy Bertrand, N ^c   Durieu, I ^d   Broussolle, C ^a  

^a HÔTEL DIEU   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Aspergillosis; Immunosuppressive drugs; Steroids; Systemic disesases

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; VORICONAZOLE; CORTICOSTEROID;

ADULT; AGED; ARTICLE; BRAIN BIOPSY; BRAIN INFECTION; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; LUNG ASPERGILLOSIS; LUNG LAVAGE; LYMPHOCYTOPENIA; MALE; MICROSCOPIC POLYANGIITIS; MICROSCOPY; POLYMYOSITIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SERODIAGNOSIS; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPORAL ARTERITIS; TREATMENT OUTCOME; ASPERGILLOSIS; CASE REPORT; CLINICAL TRIAL; DRUG COMBINATION; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; REVIEW;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; ASPERGILLOSIS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMYOSITIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; TEMPORAL ARTERITIS;

EID: 33751042437     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.07.007     Document Type: Article

References (52)

1. Kontoyiannis D.P., and Bodey G.P. Invasive aspergillosis in 2002: an update. Eur. J. Clin. Microbiol. Infect. Dis. 21 (2002) 161-172
2. Palmer L.B., Greenberg H.E., and Schiff M.J. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 46 (1991) 15-20
3. Bodey G.P., and Vartivarian S. Aspergillosis. Eur. J. Clin. Microbiol. Infect. Dis. 8 (1989) 413-437
4. Denning D.W., and Stevens D.A. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev. Infect. Dis. 12 (1990) 1147-1201
5. Denning D.W., Riniotis K., Dobrashian R., and Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin. Infect. Dis. 37 (2003) S265-S280
6. Lortholary O., Ascioglu S., Moreau P., Herbrecht R., Marinus A., Casassus P., et al. Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe français du Myelome. Clin. Infect. Dis. 30 (2000) 41-46
7. Lionakis M.S., and Kontoyiannis D.P. Glucocorticoids and invasive fungal infections. Lancet 362 (2003) 1828-1838
8. Graham B.S., and Tucker W.S. Opportunistic infections in endogenous Cushing's syndrome. Ann. Intern. Med. 101 (1984) 334-338
9. Gonzales-Crespo M.R., and Gomez-Reino J.J. Invasive aspergillosis in systemic lupus erythematosus. Semin. Arthr. Rheum. 24 (1995) 304-314
10. Haupt H.M., Moore G.W., and Hutchins G.M. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am. J. Med. 71 (1981) 791-798
11. Winterbauer R.H., and Kraemer K.G. The infectious complications of sarcoidosis: a current perspective. Arch. Intern. Med. 136 (1976) 1356-1362
12. Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., Crokaert F., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34 (2002) 7-14
13. Salaki J.S., Louria D.B., and Chmel H. Fungal and yeast infections of the central nervous system. A clinical review. Medicine 63 (1984) 108-132
14. Walsh T.J., and Lee J.W. Prevention of invasive fungal infections in patients with neoplastic disease. Clin. Infect. Dis. 17 (1993) S468-S480
15. Cleri D.J., Moser R.L., Villota F.J., Wang Y., Husain S.A., Nadeem S., et al. Pulmonary aspergillosis and central nervous system hemorrhage as complications of autoimmune hemolytic anemia treated with corticosteroids. South. Med. J. 96 (2003) 592-595
16. Angelotti T., Krishna G., Scott J., Berry G., and Weinacker A. Nodular invasive tracheobronchitis due to Aspergillus in a patient with systemic lupus erythematosus. Lupus 11 (2002) 325-328
17. Morelli S., Sgreccia A., Bernardo M.L., Della Rocca C., Gallo A., and Valesini G. Primary aspergillosis of the larynx in a patient with Felty's syndrome. Clin. Exp. Rheumatol. 18 (2000) 523-524
18. Naidech A. A young woman with ring-enhancing lesions. J. La. State Med. Soc. 155 (2003) 158-161
19. Apostolidis J., Tsandekidi M., Kousiafes D., Pagoni M., Mitsouli C., Karmiris T., et al. Short-course corticosteroid-induced pulmonary and apparent cerebral aspergillosis in a patient with idiopathic thrombocytopenic purpura. Blood 98 (2001) 2875-2877
20. Kristan S.S., Kern I., and Music E. Invasive pulmonary aspergillosis. Respiration (Herrlisheim) 69 (2002) 521-525
21. Vandenberghe P., Zachee P., Verstraete S., Demuynck H., Boogaerts M.A., and Verhoef G.E. Successful control of refractory and life-threatening autoimmune hemolytic anemia with intravenous immunoglobulins in a man with the primary antiphospholipid syndrome. Ann. Hematol. 73 (1996) 253-256
22. Cherasse A., Herin M., Oana M., and Marievoet C. Aspergillus prostatitis and prolonged corticotherapy. Apropos of a case report. Acta Urol. Belg. 65 (1997) 43-48
23. Vinas F.C., King P.K., and Diaz F.G. Spinal Aspergillus osteomyelitis. Clin. Infect. Dis. 28 (1999) 1223-1229
24. Tack K.J., Rhame F.S., Brown B., and Thompson Jr. R.C. Aspergillus osteomyelitis. Report of four cases and review of the literature. Am. J. Med. 73 (1982) 295-300
25. Hara K.S., Ryu J.H., Lie J.T., and Roberts G.D. Disseminated Aspergillus terreus infection in immunocompromised hosts. Mayo Clin. Proc. 64 (1989) 770-775
26. Katz A., Ehrenfeld M., Livneh A., Bank I., Gur H., Pauzner R., et al. Aspergillosis in systemic lupus erythematosus. Semin. Arthritis Rheum. 26 (1996) 635-640
27. Nenoff P., Horn L.C., Mierzwa M., Leonhardt R., Weidenbach H., Lehmann I., et al. Peracute disseminated fatal Aspergillus fumigatus sepsis as a complication of corticoid-treated systemic lupus erythematosus. Mycoses 38 (1995) 467-471
28. Pillay V.K., Wilson D.M., Ing T.S., and Kark R.M. Fungus infection in steroid-treated systemic lupus erythematosus. JAMA 205 (1968) 261-265
29. Cohen J., Pinching A.J., Rees A.J., and Peters D.K. Infection and immunosuppression. A study of the infective complications of 75 patients with immunologically-mediated disease. Q. J. Med. 51 (1982) 1-15
30. Ginzler E., Diamond H., Kaplan D., Weiner M., Schlesinger M., and Seleznick M. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum. 21 (1978) 37-44
31. Hellmann D.B., Petri M., and Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine 66 (1987) 341-348
32. Carpenter R.R., and Sturgill B.C. The course of systemic lupus erythematosus. J. Chronic Dis. 19 (1966) 117-131
33. Kattwinkel N., Cook L., and Agnello V. Overwhelming fatal infection in a young woman after intravenous cyclophosphamide therapy for lupus nephritis. J. Rheumatol. 18 (1991) 79-81
34. Keye Jr. J.D., and Magee W.E. Fungal diseases in a general hospital; a study of 88 patients. Am. J. Clin. Pathol. 26 (1956) 1235-1253
35. Wang Q.L., Yin J.N., and Han Z.R. A case of fulminant systemic lupus erythematosus complicated by severe aspergillar septicemia confirmed by pathologic findings. Chin. Med. J. (Engl.) 99 (1986) 493-497
36. Kimura M., Udagawa S., Shoji A., Kume H., Iomori M., Satou T., et al. Pulmonary aspergillosis due to Aspergillus terreus combined with staphylococcal pneumonia and hepatic candidiasis. Mycopathologia 111 (1990) 47-53
37. Lammens M., Robberecht W., Waer M., Carton H., and Dom R. Purulent meningitis due to aspergillosis in a patient with systemic lupus erythematosus. Clin. Neurol. Neurosurg. 94 (1992) 39-43
38. Young R.C., Bennett J.E., Vogel C.L., Carbone P.P., and DeVita V.T. Aspergillosis. The spectrum of the disease in 98 patients. Medicine 49 (1970) 147-173
39. Gottschalk J., and Eggert W. Generalisierte endomykose nach hochdosierter immunosuppresiver therapie. Dt Gesundh-Wesen 36 (1981) 2070-2072
40. Juega J., Pedreira J.D., Adega M., Valdes F., and Echaniz A. Infection in systemic lupus erythematosus. Rev. Clin. Esp. 184 (1989) 245-246
41. Molina M., Ortega G., de Paco M., and Sempere M. Nodular pulmonary infiltrates and cardiac insufficiency. Enferm. Infecc. Microbiol. Clin. 9 (1991) 655-656
42. Suragawa A., Ebina K., Hirano T., Ohi H., Yoshimura S., and Akabane M. Multiple Aspergillus brain abscess complicated with systemic lupus erythematosus. Case report. Neurol. Med. Chir. (Tokyo) 31 (1991) 986-990
43. Collazos J., Martinez E., Flores M., and Mayo J. Aspergillus pneumonia successfully treated with itraconazole in a patient with systemic lupus erythematosus. Clin. Investig. 72 (1994) 920-921
44. Urowitz M.B., Bookman A.A., Koehler B.E., Gordon D.A., Smythe H.A., and Ogryzlo M.A. The bimodal mortality pattern of systemic lupus erythematosus. Am. J. Med. 60 (1976) 221-225
45. Lisbona R., Lacourciere Y., and Rosenthall L. Aspergillomatous abscesses of the brain and thyroid. J. Nucl. Med. 14 (1973) 541-542
46. Friedmann A.M., King K.E., Shirey R.S., Resar L.M., and Casella J.F. Fatal auto-immune hemolytic anemia in a child due to warm-reactive immunoglobulin M antibody. J. Pediatr. Hematol. Oncol. 20 (1998) 502-505
47. Garcia A., Mazuecos A., Clayo A., Perez-Requena J., Mangas A., Alonso F., et al. Isolated cerebral aspergillosis without a portal of entry-complete recovery after liposomal amphotericin B and surgical treatment. Nephrol. Dial. Transplant. 13 (1998) 2385-2387
48. Wiggins Jr. R.E. Invasive aspergillosis. A complication of treatment of temporal arteritis. J. Neuroophthalmol. 15 (1995) 36-38
49. Remiszewski P., Langfort R., Podsiadlo B., Kus J., Plodziszewska M., Radzikowska E., et al. Invasive aspergillosis in autopsy material of patients treated at the Institute of Tuberculosis and Chest Diseases during the years 1993-2000. Pneumonol. Alergol. Pol. 70 (2002) 251-257
50. es Journées nationales d'infectiologie.
51. Herbrecht R., Denning D.W., Patterson T.F., Bennet J.E., Greene R.E., Oestmann J.W., et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. 347 (2002) 408-415
52. Nivoix Y., Zamfir A., Lutun P., Kara F., Remy V., Lioure B., et al. Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections. J. Infect. 52 (2006) 67-74